Introduction to InnoModels' PDC In Vitro High-Throughput Drug Efficacy Evaluation Platform

Introduction

InnoModels takes the lead in the field of medical research, proudly presenting our groundbreaking achievement: the PDC In Vitro High-Throughput Drug Efficacy Evaluation Platform. Utilizing cutting-edge techniques, we derive highly consistent primary cells from PDX model digestions that closely resemble patient profiles. This platform redefines drug development and clinical treatment by offering precise and reliable drug efficacy evaluations. Join us as we delve into this pioneering platform that is revolutionizing the landscape of drug evaluation.

Platform Highlights

● Highly Consistent Primary Cells

Our platform leverages the digestion products of PDX models to obtain primary cells that exhibit remarkable consistency with patient profiles. These cells encompass complex cellular subpopulations and biological characteristics, mirroring drug interactions and responses more closely to clinical scenarios.

● Clinical Correlation of Drug Efficacy Response

Our platform isn't limited to drug and model screenings—it extends to predicting clinical effectiveness. By comparing the efficacy of investigational drugs against benchmark drugs (such as those with similar mechanisms or standardized treatments), we can predict the clinical value of drugs.

● Multidimensional Applications

This platform transcends mere drug screening; its applications span multiple dimensions. We can identify drug indications by comparing the efficacy rates across different cancer types' models. Additionally, contrasting gene feature differences between sensitive and resistant models allows us to identify biomarkers predictive of drug efficacy.

● Pioneering a New Era

InnoModels' PDC In Vitro High-Throughput Drug Efficacy Evaluation Platform introduces unprecedented precision and reliability to drug development and clinical treatment. We focus not only on screening drugs but also on foreseeing their clinical potential. Join us in pioneering a new era, infusing innovation and progress into the field of drug evaluation. Contact us to explore the boundless potential of this innovative platform that is reshaping drug development!  #InnoModelsPDCInVitro #DrugEvaluationInnovation

Case: In vitro pharmacological screening of the test drug on ovarian cancer PDX model digested cells.